Ute Egerland

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

Steven M. Grauer, Virginia Pulito, Rachel L. Navarra et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 265 citations

Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors

Michael S. Malamas, Yike Ni, James Erdei et al. · Journal of Medicinal Chemistry · 2011 · 72 citations · Full text

Medicinal Chemistry, Drug Target, Pharmaceutical Science +15

New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity

Hans‐Joachim Lankau, Klaus Unverferth, Christian Grunwald et al. · European Journal of Medicinal Chemistry · 2007 · 70 citations

Derivatives, Medicine, Mechanism Of Action +7

Discovery of Imidazo[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors

Norbert Höfgen, Hans Stange, Rudolf Schindler et al. · Journal of Medicinal Chemistry · 2010 · 63 citations · Full text

Crystal Structure, Bioorganic Chemistry, Pharmacotherapy +16

Anti-Inflammatory Potential of the Selective Phosphodiesterase 4 Inhibitor N-(3,5-Dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), in Human Cell Preparations

Regina Draheim, Ute Egerland, Chris Rundfeldt · Journal of Pharmacology and Experimental Therapeutics · 2004 · 51 citations